Plant-based Enteral Nutrition Tolerance and Benefit in Pediatric Crohn’s Disease: A Case Series

Authors: Daniel Orellana, MD; Natasha Avila, RD; Melissa Bailey, MS, RD, CNSC, LDN; Karla Au Yeung, MD

Abstract accepted by the American Society for Parenteral and Enteral Nutrition (ASPEN) and published in the March 2020 digital supplement of the Journal of Parenteral and Enteral Nutrition (JPEN)1.

The purpose of this study was to assess the outcomes of three pediatric Crohn’s disease patients in clinical remission who were started on pediatric peptide plant-based enteral nutrition (PPBEN) in conjunction with Crohn’s disease exclusion diet (CDED). Questionnaires were conducted, labs were analyzed, and anthropometrics were measured.

Pediatric patients with Crohn’s disease who switched2 to Kate Farms had:

  • Weight gain and Increased BMI z-scores3.

  • Improved tolerance and adherence4.

Read full abstract below.

References

1. Orellana, D., et al. Plant-based enteral nutrition tolerance and benefit in pediatric Crohn’s disease: A case series. JPEN. 2020; 44(3):190-191.

2. Patients were either taking casein-based pediatric peptide or elemental formula before trial of plant-based enteral nutrition.

3. All patients in the case series had weight gain and improved BMI z-scores.

4. All patients experienced less bloating, gas, fullness, and less gastroesophageal reflux; all patients received the prescribed volume more routinely.